Full Dose Heparin Vs. Prophylactic Or Intermediate Dose Heparin in High Risk COVID-19 Patients
Clinical trial NCT04401293 · COMPLETED
Trial details
- NCT number
- NCT04401293
- Sponsor
- Northwell Health
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-26
- Primary completion
- 2021-05-14
- Enrollment
- 257
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.